Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
New York private equity concern Capital Z is putting £11 million into financial broker Jelf Group and taking investment group 3i’s near-28 per cent stake.
Capital Z is participating in a £19 million placing of ordinary shares and non-voting convertible shares from Jelf at a price of 36p. The US group will emerge with at least 25 per cent but less than a bid-triggering 30 per cent of the AIM-quoted company.
The proposed fund raising coincides with news that Jelf turned a £3.5 million profit into an £11.3 million loss on turnover up 11 per cent to £70.3 million in the year to last September. Earnings before interest, tax, depreciation and amortisation slipped nearly 20 per cent to £8.1 million, which Jelf says reflects the ‘difficult economic conditions experienced by our clients'.
Efforts to streamline the company took their toll on the pre-tax figure, after £4.7 million of reorganisation and rationalisation costs, £4.7 million of intangible fixed assets amortisation and £7.5 million of impairment charges. Chief executive Alex Alway says Jelf’s employee benefits side did well, while insurance was somewhat down but ‘resilient’ in difficult circumstances.
He stresses ‘positive developments’, including ‘£15 million off net debt’ and £24 million of new senior debt facilities. Rationalisation costs hit 2008-09’s results, but the benefits will show through later. Encouraged by support from Capital Z and others, Jelf is investing in a new 15,000 sq ft office in Manchester and maintaining its expansionist stance. Alway says he is looking for 'bolt-on acquisitions’.
Jelf shares, which traded at around 250p three years ago, but hit a 34p low over the past 12 months, now stand at 43.5p, up 0.56p today and valuing the company at £21.4 million. Capital Z’s investment could support a speculative recovery punt for the bold.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
AIM-quoted Chariot Oil and Gas (CHAR) has completed a 3D seismic survey across its central blocks.